Jazz Pharmaceuticals
JAZZ
JAZZ
501 hedge funds and large institutions have $6.56B invested in Jazz Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 187 increasing their positions, 180 reducing their positions, and 101 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
9% less funds holding
Funds holding: 548 → 501 (-47)
12% less capital invested
Capital invested by funds: $7.44B → $6.56B (-$883M)
42% less first-time investments, than exits
New positions opened: 59 | Existing positions closed: 101
Holders
501
Holding in Top 10
11
Calls
$69.8M
Puts
$8.34M
Top Buyers
| 1 | +$127M | |
| 2 | +$67.9M | |
| 3 | +$65.4M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$47.8M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$32.3M |
Top Sellers
| 1 | -$31.8M | |
| 2 | -$31.2M | |
| 3 | -$29.8M | |
| 4 |
PCM
Polaris Capital Management
Boston,
Massachusetts
|
-$26M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$23.3M |
